Position in MRK
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$642
+$638 QoQ
Shares Held
5
-90.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#3,763
of 3,769 holders
Holding Since
Mar 2025
2 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Evolution Advisers, Inc. holds $209,630 across 10 Drug Manufacturers - General names. MRK ranks #5 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
509 | $129,270 | |
| 2 | AMGN |
Amgen Inc
|
202 | $73,148 | |
| 3 | LLY |
ELI LILLY & Co
|
3 | $3,598 | |
| 4 | ABBV |
AbbVie Inc.
|
5 | $1,258 | |
| 5 | MRK |
Merck & Co., Inc.
This page
|
5 | $642 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
4 | $505 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
8 | $460 | |
| 8 | OGN |
Organon & Co.
|
27 | $365 |
All Filings in MRK
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $642 | 5 | Shares | Sole | 2026-07-31 | |
| 2025-03-31 | $4 | 50 | Shares | Sole | 2025-05-09 | |
| No filing history on record for this holder in this stock. | ||||||